The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Missed this workshop? You can now access the replay on Transplant Live as part of the online series, Quality of care in post-transplant Infectious disease course. You must be an ESOT member to access the replay. Explore complex clinical scenarios in the management of CMV infection in solid organ transplantation. CMV continues to present significant
The European Society for Organ Transplantation (ESOT) reaffirms its mission to protect patients living with, or in need of, life-sustaining therapies for end-stage organ disease, and to uphold the ethical foundations of medical care, regardless of geography, nationality, or political context.
ESOT invites applications for the role of Editor in Chief of Transplant International. Term begins 1 March 2026.
Deadline: 31 December 2025.
The European Society for Organ Transplantation (ESOT) is pleased to announce that applications are now open for the HESPERIS Course 2026, which will take place from 16 to 18 April 2026 in Rotterdam. The HESPERIS Course is a comprehensive and immersive educational programme designed for physicians, surgeons, and scientists entering the field of organ transplantation.
ESOT is hosting an online workshop on 9 December from 18:00 to 19:30 to explore complex clinical scenarios in the management of CMV infection in solid organ transplantation. CMV continues to present significant challenges for transplant teams, particularly in cases that fail to respond to therapy or are complicated by co morbidities. The session brings
